STERIS plc (STE) stock
STENYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends March 31
Financials through Q2 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 21/303% below fair value
$253.44−2.83 (-1.10%)
Close on Nov 12, 2026Market cap $24.71BP/E 30.1Yield 0.97%
Steris total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Steris's total debt was $1.89B at Sep 30, 2026. For fiscal 2026 it was $1.93B, down 5.5% from the year before. The highest annual figure on record is $3.21B in fiscal 2024.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | $1.93B | -5.5% |
| FY2025 | Mar 31, 2025 | $2.04B | -36.3% |
| FY2024 | Mar 31, 2024 | $3.21B | +4.1% |
| FY2023 | Mar 31, 2023 | $3.08B | -0.3% |
| FY2022 | Mar 31, 2022 | $3.09B | +87.1% |
| FY2021 | Mar 31, 2021 | $1.65B | +43.5% |
| FY2020 | Mar 31, 2020 | $1.15B | -2.8% |
| FY2019 | Mar 31, 2019 | $1.18B | -10.1% |
| FY2018 | Mar 31, 2018 | $1.32B | – |
Quarterly total debt
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2027CQ3 2026 | Sep 30, 2026 | $1.89B | -0.2% |
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | $1.89B | -0.5% |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | $1.93B | -5.5% |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | $1.90B | -12.3% |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | $1.90B | -15.2% |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | $1.90B | -17.8% |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | $2.04B | -36.3% |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | $2.16B | -34.6% |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | $2.24B | -34.9% |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | $2.32B | -20.8% |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | $3.21B | +4.1% |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | $3.31B | +8.1% |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $3.44B | +13.6% |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | $2.92B | -2.5% |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | $3.08B | -0.3% |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | $3.06B | -7.3% |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | $3.02B | -12.2% |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | $3.00B | -8.2% |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | $3.09B | +87.1% |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | $3.30B | +92.8% |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | $3.44B | +237.4% |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | $3.26B | +208.7% |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | $1.65B | +43.5% |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | $1.71B | +50.7% |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | $1.02B | -14.0% |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | $1.06B | -12.6% |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | $1.15B | -2.8% |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | $1.14B | -13.6% |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | $1.19B | – |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | $1.21B | – |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | $1.18B | – |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | $1.32B | – |
See a number that looks wrong?